NewcelX NCEL
NASDAQ NCEL
$3.26 -0.11 (-3.18%)
As of: Aug 21, 2026 · 1:20 PM EDT

NewcelX (NCEL) Current Leases (2022 - 2024)

NewcelX (NCEL) posted quarterly Current Leases of $144000.0 for Q2 2024, down 66.43% year-over-year from $429000.0 in Q3 2023, and down 60.11% quarter-over-quarter from $361000.0 in Q4 2023.

NewcelX (NCEL) Current Leases (2022 - 2024) Analysis & Trends

NewcelX (NCEL) has reported Current Leases for 3 consecutive years, with $144000.0 the latest figure, recorded in Q2 2024.

  • In Q2 2024, Current Leases fell 66.43% year-over-year to $144000.0; the TTM figure through Jun 2024 stood at $144000.0 (down 66.43% YoY), while the FY2023 annual figure was $361000.0, down 9.07% from the prior year.
  • Current Leases eased to $144000.0 in Q2 2024 per NCEL's latest filing, from $361000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $429000.0 in Q2 2023 and bottomed at $144000.0 in Q2 2024.
  • Historically, Current Leases has averaged $332750.0 across 3 years, with a median of $379000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Current Leases retreated 9.07% — and 2024, when it sank 66.43%.
  • NewcelX's Current Leases stood at $397000.0 in 2022, then slipped by 9.07% to $361000.0 in 2023, then tumbled by 60.11% to $144000.0 in 2024.
  • Business Quant data shows NCEL's Current Leases at $144000.0 in Q2 2024, $361000.0 in Q4 2023, and $429000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.83 Bn 130.98 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.79 Bn 77.79 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 64.95 Bn 59.77 Bn 1.37 Bn -
4 Moderna 58.59 Bn 53.46 Bn 52.00 Mn -
5 BeOne Medicines 41.93 Bn 36.83 Bn 1.53 Bn 21.95 Mn
6 Alnylam Pharmaceuticals 31.52 Bn 28.21 Bn 992.69 Mn 45.93 Mn
7 BioNTech SE 27.98 Bn 9.58 Bn 668.28 Mn -
8 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 6.27 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn - -
10 NewcelX 12.54 Mn 10.34 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 144,000.00
Dec 31, 2023 361,000.00
Jun 30, 2023 429,000.00
Dec 31, 2022 397,000.00